1 Min Read
Dec 23 (Reuters) - Protalix Biotherapeutics Inc :
* Highbridge Capital Management Reports 5.3 Pct passive stake in Protalix Biotherapeutics Inc as of Dec. 13 Source text: (bit.ly/2ioIPpE) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.